Anna Girardi

Agenzia Regionale di Sanità della Toscana (ARS Toscana), Florence, Italy, Italy

Poster(s):

• (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-141) Contribution to the Development of the ATC/DDD Classification System from Italian Working Group on DDD: Assigning a Defined Daily Dose (DDD) to Anti-Angiogenic Drugs (ATC S01LA)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-068) Impact of andexanet alfa introduction on mortality and thromboembolic events, before and after Tuscan guidelines, in patients treated with rivaroxaban or apixaban with major bleeding
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (SLC-053) Risk of Venous Thrombosis With Thrombocytopenia Syndrome After Vaccination With AZD1222: A European VAC4EU Post-Authorisation Safety Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET